An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris
Conditions:   Candidemia;   Invasive Candidiases;   Candida Infection Intervention:   Drug: APX001 Sponsor:   Amplyx Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Molecular Characterization of Candida Auris
Condition:   Oral Fungal Infection Intervention:   Other: No intervention Sponsor:   Islamia University of Bahawalpur Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials